BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20349321)

  • 1. Synthesis of α-carboxyphosphinopeptides derived from norleucine.
    Pícha J; Buděšínský M; Fiedler P; Sanda M; Jiráček J
    Amino Acids; 2010 Nov; 39(5):1265-80. PubMed ID: 20349321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
    Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
    Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient synthesis of Fmoc-protected phosphinic pseudodipeptides: Building blocks for the synthesis of matrix metalloproteinase inhibitors.
    Bhowmick M; Sappidi RR; Fields GB; Lepore SD
    Biopolymers; 2011; 96(1):1-3. PubMed ID: 20225219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
    Grembecka J; Mucha A; Cierpicki T; Kafarski P
    J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual stereoisomers of phosphinic dipeptide inhibitor of leucine aminopeptidase.
    Mucha A; Lämmerhofer M; Lindner W; Pawełczak M; Kafarski P
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1550-4. PubMed ID: 18262419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastereoselective synthesis of alpha,beta'-disubstituted aminomethyl(2-carboxyethyl)phosphinates as phosphinyl dipeptide isosteres.
    Yamagishi T; Ichikawa H; Haruki T; Yokomatsu T
    Org Lett; 2008 Oct; 10(19):4347-50. PubMed ID: 18781768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method for the synthesis of phosphinic acids from hypophosphites. V. The synthesis of pseudo-alpha,alpha-dipeptides.
    Rozhko LF; Ragulin VV
    Amino Acids; 2005 Aug; 29(2):139-43. PubMed ID: 15880266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and modifications of phosphinic dipeptide analogues.
    Mucha A
    Molecules; 2012 Nov; 17(11):13530-68. PubMed ID: 23154272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
    Matziari M; Bauer K; Dive V; Yiotakis A
    J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual activity pattern of leucine aminopeptidase inhibitors based on phosphorus containing derivatives of methionine and norleucine.
    Pícha J; Liboska R; Buděšínský M; Jiráček J; Pawełczak M; Mucha A
    J Enzyme Inhib Med Chem; 2011 Apr; 26(2):155-61. PubMed ID: 20578976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A versatile annulation protocol toward novel constrained phosphinic peptidomimetics.
    Nasopoulou M; Georgiadis D; Matziari M; Dive V; Yiotakis A
    J Org Chem; 2007 Sep; 72(19):7222-8. PubMed ID: 17715974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convenient synthesis of N-methylamino acids compatible with Fmoc solid-phase peptide synthesis.
    Biron E; Kessler H
    J Org Chem; 2005 Jun; 70(13):5183-9. PubMed ID: 15960522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An efficient and highly selective deprotection of N-Fmoc-alpha-amino acid and lipophilic N-Fmoc-dipeptide methyl esters with aluminium trichloride and N,N-dimethylaniline.
    Di Gioia ML; Leggio A; Le Pera A; Siciliano C; Liguori A; Sindona G
    J Pept Res; 2004 Apr; 63(4):383-7. PubMed ID: 15102056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortcut to fmoc-protected phosphinic pseudodipeptidic blocks.
    Matziari M; Yiotakis A
    Org Lett; 2005 Sep; 7(18):4049-52. PubMed ID: 16119964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoselective protection of solid-phase compatible Fmoc-phosphinic building blocks.
    Nasopoulou M; Matziari M; Dive V; Yiotakis A
    J Org Chem; 2006 Dec; 71(25):9525-7. PubMed ID: 17137389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of in situ silylation for improved, convenient preparation of fluorenylmethoxycarbonyl (Fmoc)-protected phosphinate amino acids.
    Li S; Whitehead JK; Hammer RP
    J Org Chem; 2007 Apr; 72(8):3116-8. PubMed ID: 17375960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of phosphinic tripeptide inhibitors of cathepsin C.
    Mucha A; Paweł M; Hurek J; Kafarski P
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3113-6. PubMed ID: 15149655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the pathway toward thiophosphinic pseudopeptides. Synthesis of suitably protected PG-Phe-Ψ[P(S)(OX)CH2]-Gly-OY analogues as thiophosphinyl dipeptide isosters (TDI), a comparative study for selective deprotection and further elongation.
    Vassiliou S; Tzouma E
    J Org Chem; 2013 Oct; 78(20):10069-76. PubMed ID: 24050761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of phosphinopeptides via the Mannich ligation.
    Li B; Cai S; Du DM; Xu J
    Org Lett; 2007 Jun; 9(12):2257-60. PubMed ID: 17497867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.